Investigating a New Anti-Clotting Drug for Cats with Heart Disease
Researchers will investigate the effectiveness of a new anticoagulant drug to prevent abnormal and deadly blood clotting complications in cats with heart disease.
Researchers will investigate the effectiveness of a new anticoagulant drug to prevent abnormal and deadly blood clotting complications in cats with heart disease.
Researchers will search for genetic mutations associated with mitral valve disease, a common heart condition in small breed dogs, to improve disease management and prevention.
Researchers will investigate the effectiveness of a clot buster in cats with severe heart disease.
Researchers will investigate the effectiveness of a transdermal gel formulation of a drug used to treat cats with congestive heart failure.
This study investigates ways to improve early detection of cardiomyopathy (heart disease) by primary care veterinarians in pet cats.
This fellowship will characterize cardiomyopathy in Golden Retrievers and identify genes that contribute to phenotypic severity, which should improve detection and treatment of cardiomyopathy.
This study will evaluate dogs with heart disease for a common genetic variant to determine whether this variant affects their ability to respond to heart medications.